Wolverine Trading, LLC Citius Pharmaceuticals, Inc. Transaction History
Wolverine Trading, LLC
- $96.9 Billion
- Q2 2025
Shares
2 transactions
Others Institutions Holding CTXR
# of Institutions
4Shares Held
1.96MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY1.81MShares$2.74 Million0.0% of portfolio
-
Key Bridge Compliance, LLC Covington, KY154KShares$234,2770.03% of portfolio
-
American Portfolios Advisors Holbrook, NY4KShares$6,0800.0% of portfolio
-
Clear Perspectives Financial Planning, LLC Cincinnati, OH400Shares$6080.0% of portfolio
About Citius Pharmaceuticals, Inc.
- Ticker CTXR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 146,130,000
- Market Cap $222M
- Description
- Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...